Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Insulin-dependent Diabetes MellitusDiabetes Mellitus

Interventions

BIOLOGICAL

IBC-VS01

BIOLOGICAL

IBC-VS01 placebo

Trial Locations (2)

Children's Hospital, Boston

Joslin Diabetes Center, Boston

All Listed Sponsors

collaborator

Immune Tolerance Network (ITN)

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00057499 - Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics | Biotech Hunter | Biotech Hunter